Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seol, D.-W.
Right arrow Articles by Billiar, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seol, D.-W.
Right arrow Articles by Billiar, T. R.
[Cancer Research 61, 1138-1143, February 1, 2001]
© 2001 American Association for Cancer Research


Regular Articles

Signaling Events Triggered by Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL): Caspase-8 Is Required for TRAIL-induced Apoptosis1

Dai-Wu Seol2, Jianrong Li3, Mi-Hyang Seol, Sang-Youel Park, Robert V. Talanian and Timothy R. Billiar

Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261 [D-W. S., J. L., M-H. S., S-Y. P., T. R. B.], and BASF Bioresearch Corporation, Worcester, Massachusetts 01605 [R. V. T.]

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a TNF family member and potent apoptosis inducer. In contrast to TNF-{alpha} or Fas ligand, relatively little is known about the signaling events activated by TRAIL. In particular, the initial caspase(s) required for TRAIL-induced apoptosis remains to be determined. Caspase-3-like protease but not caspase-1-like protease (YVADase) activity rapidly increased in HeLa cells in response to TRAIL treatment. The increase in protease activity correlated with the profile of apoptotic cell death that was inhibited by the pan-caspase inhibitor Z-VAD-fmk. In response to TRAIL, caspase-8, an initiator caspase in death receptor-mediated apoptosis, was activated within 1 h in association with Bid cleavage, cytochrome c release, caspase-3 activation, and DNA fragmentation factor 45 cleavage. Z-IETD-fmk, a caspase-8 inhibitor, completely blocked caspase-8 activation and resulted in inhibition of caspase-3 (a caspase-3-like protease) activation and apoptotic cell death. Overexpression of a caspase-8 dominant negative mutant inhibited apoptosis induced by TRAIL. Caspase-8-deficient Jurkat cells were resistant to both TRAIL- and Fas-induced apoptosis, whereas wild-type Jurkat cells were susceptible to both TRAIL- and Fas-induced apoptosis. The caspase-8-reintroduced caspase-8-deficient Jurkat cells acquired normal susceptibility to both TRAIL and agonistic Fas antibody. Reverse transcription-PCR and sequence analyses have revealed that these caspase-8-deficient Jurkat cells express wild-type caspase-10. Therefore, our data indicate that caspase-8 is required for TRAIL-induced apoptosis and suggest that caspase-10 may play a minor role, if any, in TRAIL-induced apoptosis.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. T. Hellwig, B. F. Kohler, A.-K. Lehtivarjo, H. Dussmann, M. J. Courtney, J. H. M. Prehn, and M. Rehm
Real Time Analysis of Tumor Necrosis Factor-related Apoptosis-inducing Ligand/Cycloheximide-induced Caspase Activities during Apoptosis Initiation
J. Biol. Chem., August 1, 2008; 283(31): 21676 - 21685.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Tang and I. T. Tai
A Novel Interaction between Procaspase 8 and SPARC Enhances Apoptosis and Potentiates Chemotherapy Sensitivity in Colorectal Cancers
J. Biol. Chem., November 23, 2007; 282(47): 34457 - 34467.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. J. Song, J. Y. An, Y. T. Kwon, and Y. J. Lee
Evidence for Two Modes of Development of Acquired Tumor Necrosis Factor-related Apoptosis-inducing Ligand Resistance: INVOLVEMENT OF Bcl-xL
J. Biol. Chem., January 5, 2007; 282(1): 319 - 328.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Huang, N. Erdmann, H. Peng, S. Herek, J. S. Davis, X. Luo, T. Ikezu, and J. Zheng
TRAIL-Mediated Apoptosis in HIV-1-Infected Macrophages Is Dependent on the Inhibition of Akt-1 Phosphorylation
J. Immunol., August 15, 2006; 177(4): 2304 - 2313.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. Cheng, B. L. Hylander, M. R. Baer, X. Chen, and E. A. Repasky
Multiple mechanisms underlie resistance of leukemia cells to Apo2 Ligand/TRAIL.
Mol. Cancer Ther., July 1, 2006; 5(7): 1844 - 1853.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. G. Clohessy, J. Zhuang, J. de Boer, G. Gil-Gomez, and H. J. M. Brady
Mcl-1 Interacts with Truncated Bid and Inhibits Its Induction of Cytochrome c Release and Its Role in Receptor-mediated Apoptosis
J. Biol. Chem., March 3, 2006; 281(9): 5750 - 5759.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Guo, C. Chen, Y. Zheng, J. Zhang, X. Tao, S. Liu, D. Zheng, and Y. Liu
A Novel Anti-human DR5 Monoclonal Antibody with Tumoricidal Activity Induces Caspase-dependent and Caspase-independent Cell Death
J. Biol. Chem., December 23, 2005; 280(51): 41940 - 41952.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
R. Shao, D.-F. Lee, Y. Wen, Y. Ding, W. Xia, B. Ping, H. Yagita, B. Spohn, and M.-C. Hung
E1A Sensitizes Cancer Cells to TRAIL-Induced Apoptosis through Enhancement of Caspase Activation
Mol. Cancer Res., April 1, 2005; 3(4): 219 - 226.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. N. Shin, Y. W. Seo, M. Kim, S.-Y. Park, M.-J. Lee, B. R. Lee, J.-W. Oh, D.-W. Seol, and T.-H. Kim
Cisplatin Inactivation of Caspases Inhibits Death Ligand-induced Cell Death in Vitro and Fulminant Liver Damage in Mice
J. Biol. Chem., March 18, 2005; 280(11): 10509 - 10515.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Kim, S.-Y. Park, H.-S. Pai, T.-H. Kim, T. R. Billiar, and D.-W. Seol
Hypoxia Inhibits Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis by Blocking Bax Translocation
Cancer Res., June 15, 2004; 64(12): 4078 - 4081.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Song, R. S. Mahidhara, Z. Zhou, R. A. Hoffman, D.-W. Seol, R. A. Flavell, T. R. Billiar, L. E. Otterbein, and A. M. K. Choi
Carbon Monoxide Inhibits T Lymphocyte Proliferation via Caspase-Dependent Pathway
J. Immunol., January 15, 2004; 172(2): 1220 - 1226.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Mezosi, S. H. Wang, S. Utsugi, L. Bajnok, J. D. Bretz, P. G. Gauger, N. W. Thompson, and J. R. Baker Jr.
Interleukin-1{beta} and Tumor Necrosis Factor (TNF)-{alpha} Sensitize Human Thyroid Epithelial Cells to TNF-Related Apoptosis-Inducing Ligand-Induced Apoptosis through Increases in Procaspase-7 and Bid, and the Down-Regulation of p44/42 Mitogen-Activated Protein Kinase Activity
J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 250 - 257.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. A. Kopecky and D. S. Lyles
Contrasting Effects of Matrix Protein on Apoptosis in HeLa and BHK Cells Infected with Vesicular Stomatitis Virus Are due to Inhibition of Host Gene Expression
J. Virol., April 15, 2003; 77(8): 4658 - 4669.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
J. C. Fanzo, C.-M. Hu, S. Y. Jang, and A. B. Pernis
Regulation of Lymphocyte Apoptosis by Interferon Regulatory Factor 4 (IRF-4)
J. Exp. Med., February 3, 2003; 197(3): 303 - 314.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Qin, B. Camoretti-Mercado, L. Blokh, C. G. Long, F. D. Ko, and K. J. Hamann
Fas Resistance of Leukemic Eosinophils Is Due to Activation of NF-{kappa}B by Fas Ligation
J. Immunol., October 1, 2002; 169(7): 3536 - 3544.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. A. Eid, R. W. Lewis, and M. V. Kumar
Mifepristone Pretreatment Overcomes Resistance of Prostate Cancer Cells to Tumor Necrosis Factor {alpha}-related Apoptosis-inducing Ligand (TRAIL)
Mol. Cancer Ther., August 1, 2002; 1(10): 831 - 840.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. H. L. Velthuis, K. M. A. Rouschop, H. J. G. M. de Bont, G. J. Mulder, and J. F. Nagelkerke
Distinct Intracellular Signaling in Tumor Necrosis Factor-related Apoptosis-inducing Ligand- and CD95 Ligand-mediated Apoptosis
J. Biol. Chem., June 28, 2002; 277(27): 24631 - 24637.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. W. Jeffrey, M. Bushell, V. J. Tilleray, S. Morley, and M. J. Clemens
Inhibition of Protein Synthesis in Apoptosis: Differential Requirements by the Tumor Necrosis Factor {alpha} Family and a DNA-damaging Agent for Caspases and the Double-stranded RNA-dependent Protein Kinase
Cancer Res., April 1, 2002; 62(8): 2272 - 2280.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Huang, Q. He, M. J. Hillman, R. Rong, and M. S. Sheikh
Sulindac Sulfide-induced Apoptosis Involves Death Receptor 5 and the Caspase 8-dependent Pathway in Human Colon and Prostate Cancer Cells
Cancer Res., September 1, 2001; 61(18): 6918 - 6924.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.